Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jan 23, 14:38
1975.65 -20.25 (-1.01%)
Volume
AVERAGE VOLUME
5-Day
19,142
10-Day
17,682
30-Day
15,534
3,821
  • Prev. Close

    1995.90

  • Open Price

    1996.00

  • Bid Price (Qty.)

    1973.90 (6)

  • Offer Price (Qty.)

    1976.45 (9)

NSE Live

Jan 23, 14:38
1975.80 -21.40 (-1.07%)
Volume
AVERAGE VOLUME
5-Day
425,001
10-Day
470,687
30-Day
541,293
340,512
  • Prev. Close

    1997.20

  • Open Price

    2000.00

  • Bid Price (Qty.)

    1974.10 (16)

  • Offer Price (Qty.)

    1975.30 (156)

Company Facts - Glenmark

Registered Address

B/2, Mahalaxmi Chambers,
,22, Bhulabhai Desai Road,
Mumbai
Maharashtra
400026

Tel: 022-40189999 022-40189879
Fax: 022-40189986
Email: complianceofficer@glenmarkpharma.com
Website: http://www.glenmarkpharma.com
Group:

Registrars

KFIN Technologies Pvt. Ltd. Selenium Tower B, Plot No. 31-32, Gachibowli, Financial District, Nanakramguda,Seri
Hyderabad - 500032
Telangana

Tel: 040-67161500, 67162222, 33211000
Fax: 040-23420814, 23001153
Email: einward.ris@karvy.com
Website: http://www.kfintech.com

Management - Glenmark

NameDesignation
Glenn Saldanha Chairman & Managing Director
Anurag Mantri Executive Director & Global CFO
Saira Ramasastry Ind. Non-Executive Director
Pradeep Kumar Sinha Ind. Non-Executive Director
NameDesignation
Cherylann Pinto Executive Director
B E Saldanha Non Executive Director
Vijayalakshmi Iyer Ind. Non-Executive Director
Dipankar Bhattacharjee Ind. Non-Executive Director
Source : Dion Global Solutions Limited
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347